News

During the meeting, a comprehensive review of past actions and plans for the upcoming months was presented. Key elements include:

1.Finalizing the work on the recommendations of two main working groups (Working Groups):

                WG1 focusing on strengthening the EU’s production capacity

                WG2 dedicated to international partnerships

2. Preparing a strategic report, scheduled for publication in January 2025, which will serve as the foundation for the European Commission’s Critical Medicines Act.

3. Launching the new HERA Stakeholders Hub platform (https://health-preparedness-industry-hub.ec.europa.eu/), which will enable:

    Access to up-to-date information and documents

    Participation in consultations and voting

    Establishing partnerships with other organizations

    Engagement in initiatives aimed at enhancing the EU’s pharmaceutical security

A particularly important aspect is the creation of an EU critical medicines list, which will be regularly updated and serve as the basis for further actions within the Alliance. Upcoming key events include the Steering Board meeting on December 18 and the presentation of the final version of the strategic report scheduled for February 12, 2025.

IRSS, as a member of the Alliance, will actively participate in the consultations on the strategic report and the work of the HERA Stakeholders Hub platform, contributing to ensuring the pharmaceutical security of the European Union.